110 related articles for article (PubMed ID: 15223879)
21. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Mirsaeidi SM; Tabarsi P; Khoshnood K; Pooramiri MV; Rowhani-Rahbar A; Mansoori SD; Masjedi H; Zahirifard S; Mohammadi F; Farnia P; Masjedi MR; Velayati AA
Int J Infect Dis; 2005 Nov; 9(6):317-22. PubMed ID: 16183321
[TBL] [Abstract][Full Text] [Related]
22. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Khodashova ML; Iuditskiĭ MV; Semenova OV
Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
[TBL] [Abstract][Full Text] [Related]
23. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
[TBL] [Abstract][Full Text] [Related]
24. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
[TBL] [Abstract][Full Text] [Related]
25. [Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
Takashima T; Danno K; Tamura Y; Nagai T; Matsumoto T; Han Y; Ano H; Yoshida H; Kawahara K; Tsuyuguchi I
Kekkaku; 2006 Jun; 81(6):413-8. PubMed ID: 16838679
[TBL] [Abstract][Full Text] [Related]
26. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens.
Han LL; Sloutsky A; Canales R; Naroditskaya V; Shin SS; Seung KJ; Timperi R; Becerra MC
Int J Tuberc Lung Dis; 2005 Jul; 9(7):818-21. PubMed ID: 16013781
[TBL] [Abstract][Full Text] [Related]
27. Mycobacterium tuberculosis resistance in HIV-infected patients from a tertiary care teaching hospital in Porto Alegre, southern Brazil.
Wolfart M; Barth AL; Willers D; Zavascki AP
Trans R Soc Trop Med Hyg; 2008 May; 102(5):421-5. PubMed ID: 18394664
[TBL] [Abstract][Full Text] [Related]
28. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents.
Drobac PC; del Castillo H; Sweetland A; Anca G; Joseph JK; Furin J; Shin S
Clin Infect Dis; 2005 Jun; 40(11):1689-92. PubMed ID: 15889370
[TBL] [Abstract][Full Text] [Related]
29. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
[No Abstract] [Full Text] [Related]
30. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
31. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
32. Drug resistance in tuberculosis--a reinfection model.
Rodrigues P; Gomes MG; Rebelo C
Theor Popul Biol; 2007 Mar; 71(2):196-212. PubMed ID: 17174368
[TBL] [Abstract][Full Text] [Related]
33. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
[TBL] [Abstract][Full Text] [Related]
34. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
35. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
36. Partial intestinal obstruction due to clofazimine in a patient with multidrug-resistant tuberculosis.
Usküdar O; Köksal D; Köksal AS
Int J Tuberc Lung Dis; 2005 Jun; 9(6):703-4. PubMed ID: 15971405
[No Abstract] [Full Text] [Related]
37. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis].
Katalinić-Janković V; Obrovac M
Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689
[TBL] [Abstract][Full Text] [Related]
38. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
[TBL] [Abstract][Full Text] [Related]
39. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
Martins M; Viveiros M; Couto I; Amaral L
Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
[TBL] [Abstract][Full Text] [Related]
40. Shortening the treatment of tuberculosis.
Mitchison DA
Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
